Actavis chief Bisaro finds prescription for growth

[at Financial Times] – Paul Bisaro, the outspoken chief executive of drugs company Actavis, has quickly gained a reputation as an ambitious dealmaker in a competitive drugs market. In the space of two years, Mr Bisaro has steered … more

View todays social media effects on ACT

View the latest stocks trending across Twitter. Click to view dashboard

See who Actavis is hiring next, click here to view